Taber et al.
JOCNote
7.55 (t, J= 7.9 Hz, 1H), 7.05 (m, 2H), 2.75 (m, 2H), 2.40-2.15
(m, 4H), 2.05 (m, 2H), 1.85 (m, 1H), 1.60 (m, 1H), 1.40 (m, 1H);
13C NMR δ u8 211.4, 159.5, 47.6, 45.1, 41.4, 31.1, 25.0; d 149.4,
136.3, 123.6, 121.4, 39.6; HRMS calcd for C12H16NO (MHþ)
190.1232, obsd 190.1237.
1H), 2.60 (m, 2H), 1.85-1.55 (m, 5H), 1.55-1.40 (m, 5H), 1.25
(s, 3H), 1.10 (m, 2H), 0.95 (d, J = 6.2 Hz, 3H); 13C NMR
(CD3OD) δ u 111.4, 65.4, 65.3, 47.6, 47.0, 46.5, 33.7, 26.7, 25.7; d
55.4, 26.2, 24.5, 21.8; HRMS calcd for C13H26NO2 (MHþ)
228.1964, obsd 228.1961.
4-Methyl-5-(pyridin-2-yl)pentan-2-one (1). To a stirred solu-
tion of 2-picoline (399 mg, 4.29 mmol) in THF (4 mL) was added
n-BuLi (4.19 mmol, 1.8 mL, 2.33 M in hexane) at -78 °C. After
being stirred at 0 °C for 1 h, the reaction mixture was cooled to
(()-Cermizine C TFA Salt (13). To a stirred solution of piperi-
dine 9 (46 mg, 0.20 mmol) in MeOH (1 mL) was added HCl (3 M,
1 mL) at room temperature. After being stirred at room tempe-
rature overnight, the reaction mixture was concentrated, includ-
ing high vacuum pumping, to give crude (()-senepodine G (11).
To a stirred solution of the above crude (()-senepodine G in
MeOH (4 mL) was added NaBH4 (20 mg, 0.52 mmol) at 0 °C.
After being stirred at room temperature for 10 min, the reaction
mixture was quenched with HCl (3 M, 2 mL) and then parti-
tioned between CH2Cl2 and, sequentially, water and brine. The
combined organic extract was dried (Na2SO4) and concentrated.
The residue was chromatographed to yield (()-cermizine C (13)
(27 mg, 80% yield) as a pale yellow oil: TLC Rf (Et2O saturated
with NH4OH) = 0.60. To a solution of the (()-cermizine C in
MeOH (0.5 mL) was added TFA5b,5c (1 drop, 20 μL, excess).
The mixture was concentrated to give (()-cermizine C TFA salt
-30 °C and added over 2 min to a stirred suspension of CuBr
3
SMe2 (425 mg, 2.06 mmol) in THF (4 mL) at -30 °C. After being
stirred for 2 h at -30 °C, the reaction mixture was cooled to -78 °C,
and a solution of 3-penten-2-one (90%, 102 mg, 1.09 mmol) in
THF (3 mL) was added over 5 min. After being stirred at -78 °C
for 2 h, the reaction mixture was quenched with water (5 mL)
and partitioned between CH2Cl2 and, sequentially, water and
brine. The combined organic extract was dried (Na2SO4) and
concentrated. The residue was chromatographed to yield ketone 1
(87 mg, 45% yield) as a pale yellow oil: TLC Rf (20% MTBE/
CH2Cl2)=0.33; IR (cm-1) 1704, 1647, 1367; 1H NMR δ 8.50 (app
s, 1H), 7.55 (m, 1H), 7.10 (m, 2H), 2.65 (m, 2H), 2.50 (m, 2H), 2.25
(m, 1H), 2.05 (s, 3H), 0.90 (d, J=6.6 Hz, 3H); 13C NMR δ u 208.7,
160.5, 50.3, 45.3; d 149.2, 136.3, 123.7, 121.2, 30.4, 30.2, 19.9;
HRMS calcd for C11H16NO (MHþ) 178.1232, obsd 178.1239.
2-(2-Methyl-3-(2-methyl-1,3-dioxolan-2- yl)propyl)pyridine (8).
To a stirred solution of ketone 1 (910 mg, 5.14 mmol) in benzene
(20 mL) were added p-toluenesulfonic acid monohydrate (120 mg,
0.60 mmol) and ethylene glycol (1.07 g, 17.3 mmol) at room tem-
perature. The reaction mixture was stirred at reflux overnight
with a Dean-Stark trap. After being cooled to room tempera-
ture, the reaction mixture was quenched with saturated aqueous
NaHCO3 (100 mL) and then partitioned between CH2Cl2 and,
sequentially, water and brine. The combined organic extract was
dried (Na2SO4) and concentrated. The residue was chromato-
graphed to yield ketal 8 (906 mg, 80% yield) as a pale yellow oil:
TLC Rf (20% MTBE/CH2Cl2) = 0.29; IR (cm-1) 2926, 1591,
1472, 1436; 1H NMR δ 8.50 (d, J=4.71 Hz, 1H), 7.55 (m, 1H),
7.05 (m, 2H), 3.90 (m, 4H), 2.85 (m, 1H), 2.55 (m, 1H), 2.20 (m,
1H), 1.70 (m, 1H), 1.55 (m, 1H), 1.30 (s, 3H), 0.95 (d, J=6.65 Hz,
3H); 13C NMR δ u 161.2, 110.3, 64.4, 64.2, 46.6, 44.9; d 149.2,
136.0, 123.6, 120.9, 30.2, 24.0, 20.7; HRMS calcd for C13H20-
NO2 (MHþ) 222.1494, obsd 222.1494.
1
as a yellow oil: IR (cm-1) 2524, 1675, 1455, 1201; H NMR
(CD3OD) δ 3.80 (m, 1H), 3.60 (m, 2H), 3.05 (m, 1H), 2.15 (m,
1H), 2.00-1.50 (m, 9H), 1.40-1.20 (m, 1H), 1.30 (d, J=6.4 Hz,
3H), 0.95 (d, J=6.4 Hz, 3H); 13C NMR (CD3OD) δ u 49.9, 41.8,
38.4, 24.6, 23.8, 18.4; d 61.4, 51.1, 25.5, 21.6, 17.6; HRMS calcd
for C11H22N (MHþ) 168.1752, obsd 168.1755.
(()-epi-Cermizine C TFA Salt (14). To a stirred solution of
piperidine 10 (40 mg, 0.18 mmol) in MeOH (1 mL) was added
HCl (3 M, 1 mL) at room temperature. After being stirred at
room temperature overnight, the reaction mixture was concen-
trated, including high vacuum pumping, to give crude (()-epi-
senepodine G (12).
To a stirred solution of the above crude (()-epi-senepodine G
in MeOH (4 mL) was added NaBH4 (15 mg, 0.39 mmol) at 0 °C.
After being stirred at room temperature for 10 min, the reaction
mixture was quenched with HCl (3 M, 2 mL) and then parti-
tioned between CH2Cl2 and, sequentially, water and brine. The
combined organic extract was dried (Na2SO4) and concen-
trated. The residue was chromatographed to yield (()-epi-
cermizine C (14) (23 mg, 78% yield) as a pale yellow oil: TLC
Rf (Et2O saturated with NH4OH) = 0.78. To a solution of the
(()-epi-cermizine C in MeOH (0.5 mL) was added TFA5b,5c
(1 drop, 20 μL, excess). The mixture was concentrated to give
(()-epi-cermizine C TFA salt as a yellow oil: IR (cm-1) 2529,
1665, 1198; 1H NMR (CD3OD) δ 3.75 (m, 1H), 3.20-3.00 (m,
2H), 2.70 (m, 1H), 2.00-1.65 (m, 7H), 1.55 (m, 2H), 1.40-1.20
(2S*)-2-((2S*)-Methyl-3-(2-methyl-1,3-dioxolan-2-yl)propyl)-
piperidine (9) and (2R*)-2-((2S*)-Methyl-3-(2-methyl-1,3-dioxo-
lan-2-yl)propyl)piperidine (10). A suspension of ketal 8 (350 mg,
1.58 mmol) and PtO2 (30 mg) in CH2Cl2 (3 mL) was stirred at
room temperature under H2 (1 atm) overnight. The reaction mix-
ture was filtered and concentrated. The residue was chromato-
graphed to yield amine 9 (172 mg, 48% yield) as a pale yellow oil
and amine 10 (170 mg, 47% yield) as a pale yellow oil.
(m, 2H), 1.35 (d, J=6.40 Hz, 3H), 0.95 (d, J=6.40 Hz, 3H); 13
C
NMR (CD3OD) δ u 51.9, 41.8, 40.4, 32.2, 24.9, 23.2; d 65.4, 62.4,
30.0, 21.4, 17.9; HRMS calcd for C11H22N (MHþ) 168.1752,
obsd 168.1752.
Piperidine 9: TLC Rf (10% Et2NH/PE) = 0.43; IR (cm-1
)
2929, 1646, 1450; 1H NMR (CD3OD) δ 3.90 (m, 4H), 3.05 (m,
1H), 2.60 (m, 2H), 1.85-1.55 (m, 5H), 1.55-1.40 (m, 5H), 1.30
(s, 3H), 1.25-1.0 (m, 2H), 0.95 (d, J = 6.6 Hz,3H); 13C NMR
(CD3OD) δ u 111.3, 65.4, 65.3, 47.4, 46.5, 45.8, 32.6, 26.4, 25.4; d
55.4, 26.1, 24.5, 22.2; HRMS calcd for C13H26NO2 (MHþ)
228.1964, obsd 228.1961.
Acknowledgment. We thank John Dykins for high-
resolution mass spectrometry under the financial support of
NSF 054117. NMR spectra were acquired with instrumenta-
tion supported by NSF CRIF:MU, CHE 080401. We thank
the NIH (GM060287) for financial support of this work.
Piperidine 10: TLC Rf (10% Et2NH/PE) = 0.49; IR (cm-1
)
2929, 1646, 1450; 1H NMR (CD3OD) δ 3.90 (m, 4H), 3.00 (m,
Supporting Information Available: General experimental
procedures and spectroscopic data. This material is available
(8) 13C multiplicities were determined with the aid of a JVERT pulse
sequence, differentiating the signals for methyl and methine carbons as “d”
and for methylene and quaternary carbons as “u”.
J. Org. Chem. Vol. 75, No. 16, 2010 5739